Dr. Jing Qin obtained her Ph.D. from Shenyang Pharmaceutical University and joint Shanghai Institute of Pharmaceutics Industry as a postdoctoral fellow. She was recruited as a lecture by School of Pharmacy, Fudan University in 2009 and became an associate professor in 2015. She did exchange research work for one year in University of North Carolina at Chapel Hill in 2015. Her research mainly focus on brain targeting drug delivery by cell-nanoparticles delivery system based on inflammation response. She was funded by National Natural Science Foundation of China, Specialized Research Fund for the Doctoral Program of Higher Education, Science and Technology Commission of Shanghai Municipality. She has published 20 papers and applied 6 patents, 2 of which were authorized successfully. She has been awarded twice with the Merck-Fudan Scholarship for Excellent Young Teachers and the Excellent Teaching Award sponsored Pharmacy School of Fudan University
Brain Targeting Drug Delivery; Cell Carrier; Ischemic Stroke Targeting Therapy; Traditional Chinses Medicine
Education
2004.9-2007.7 Shenyang Pharmaceutical University, Doctor Degree
2001.9-2004.7 Heilongjiang University of Traditional Chinese Medicine, Master Degree
Professional Experiences
2007.9-2009.8 Shanghai Institute of Pharmaceutical Industry, Postdoctor
2009.9-present School of Pharmacy, Fudan University
Teaching Activities
Dr. Jing Qin teaches “Dosage form and therapy effect”, “Nanoparticle Medicine” “Pharmacokinetics” “Biopharmaceutics” and “Traditional Chinese Medicine Study”.
Grants & Projects
1. Multi-brain-targeting drug delivery system based on nanoparticle-cell combination carrier for the whole pathogenesis process in ischemic stroke , NSFC (81673372), 2017.1-2018.12
2. cRGD modified multi-targeting drug delivery and its transport mechanism NSFC (81102386), 2012.1-2014.12
3. Study on total glucosides from Radix gentianae. Science and Technology Commission of Shanghai Municipality (11DZ1971801). 2011.11-2014.9
4. Multi-targeting drug delivery system to brain base on inflammation response. Specialized Research Fund for the Doctoral Program of Higher Education (20110071120042). 2012.1-2014.12.
5. PGP mediated multi-targeting drug delivery to brain. Key laboratory of Drug Targeting and Drug Delivery System (Sichuan University) Ministry of Education. 2015.6-2017.6
Awards & Honors
1. 2013 Merck-Fudan Scholarship for Excellent Young Teachers
2. 2014 Merck-Fudan Scholarship for Excellent Teaching Award
Invited Presentations
1. Liposome Research Day. A novel brain-targeting strategy for ischemic stroke in response to inflammation. 2012.10
2. Cell-liposome multi-carrier for targeting therapy to ischemic stroke. The third Chinese Microcirculation Week. 2018.10
Selected Publications（latest 5 yrs，<20 papers）
1. Chun Zhang, Cheng-li Ling, Liang Pang, Qi Wang, Jing-xin Liu, Bing-shan Wang, Jian-ming Liang, Yi-zhen Guo, Jing Qin*, Jian-xin Wang. Direct Macromolecular Drug Delivery to Cerebral Ischemia Area using Neutrophil-Mediated Nanoparticles. Theranostics 2017, 7, 13:3260-3275.
2. Jing Qin, Xu Yang, Ruo-Xi Zhang, Yi-Xiao Luo, Jia-Li Li, Jia Hou, Chun Zhang, Yong-Ji Li, Jie Shi, Lin Lu, Jian-Xin Wang*, Wei-Li Zhu*. Monocyte mediated brain targeting delivery of macromolecular drug for the therapy of depression. Nanomedicine: Nanotechnology, Biology and Medicine. 2015, 11(2):391-400.
3. Yong-Qin Yin, Chun Zhang, Jian-Xin Wang, Jia Hou, Xu Yang, Jing Qin*. Chronic caffeine treatment enhances the resilience to social defeat stress in mice. Food & Function. 2015, 6(2):479-491.
4. Jing Qin, Limin Wang, Lihong Wu, Jun Chen, Teng Shen, Yongji Li, Limei Han, Jianxin Wang*. Development of an LC-MS/MS method for determining the pharmacokinetics of clonidine following oral administration of Zhenju antihypertensive compound. Biomedical Chromatography. 2015, 29(7):1068-7510.
5. Jing Qin, Xu Yang, Jia Mi, Jianxin Wang, Jia Hou, Teng Shen, Yongji Li, Bin Wang, Xuri Li, Weili Zhu*. Enhanced antidepressant-like effects of the macromolecule trefoil factor 3 by loaded into negatively-charged liposomes. International Journal of Nanomedicine. 2014,9:5247-5257.
6. Jing Qin, Ruo-Xi Zhang, Jia-Li Li, Jian-Xin Wang, Jia Hou, Xu Yang, Wei-Li Zhu*, Jie Shi， Lin Lu. cRGD mediated liposomes enhanced antidepressant-like effects of edaravone in rats. European Journal of Pharmaceutical Sciences. 2014, 58: 63–71.
7. Jing Qin, Limin Wang, Yu Bai, Yongji Li, Yingchun Jing, Limei Han, Jianxin Wang*. Enhanced absorption and bioavailability of hydrochlorothiazide by Chinese medicines in the Zhenju antihypertensive compound. Journal of Pharmacy and Pharmacology. 2014, 66: 855–864.
8. Jing-Jie Yu, Yong Zhang, Ying Wang, Zi-Yu Wen, Xiao-Hua Liu, Jing Qin*, Jian-Li Yang*. Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway. Psychopharmacology. 2013, 225(2):361–372.
